Technological Advancements in Digital Pathology
The advancement is the field of the healthcare industry is driving to the players for more research and developments for the imaging devices and the required software for the digital pathology devices. The advanced systems helps labs and hospitals to add value to the testing services as this improves the performance to influence information technology. The advanced health information technology can be deployed within pathology labs and pathology groups specifically to meet the change of patient expectations, along with this it supports the needs of physicians for optimal workflow. For instance, Aperio ePathAccess of the Leica Biosystems is software which enables sharing of the digital pathology images and case data with the experts outside the information technology network.
The concern of the people staying in the remote regions is for travelling to the urban areas for the diagnosis of the diseases. The follow up for the results becomes difficult but with the help of the digital pathology the gap between the patients and diagnosing centers is bridged. Digital pathology has helped patient to reduce their travelling time and the cost of the treatments. In addition, the digital pathology set up is easy to adopt in the rural labs and the hospitals. Thus these factors are driving the growth of the digital pathology market.
Download PDF Brochure Study Here
Moreover, scanners enables quick production of, reliable and high resolution images of cells. It helps pathologists, histologists and other medical professionals to scan slides and upload the images on the network for remote access and to collaborate it among the colleagues. The automated cellular imaging for fixing cell assays and for fluorescence, phase contrast and transmit light are provided by the scanners. The advancement in the technologies has added some more integrated software along with the scanners for future analysis, editing, managing and sharing the virtual slides. Thus, owing to these factors the market for digital pathology systems/ devices are likely to propel the growth for the market of digital pathology in the coming years.
In addition it allows the sharing of the data across the organization and other regions through the internet. Moreover, some of the companies such as Visiopharm, Indica Labs among the other market players are focused to provide software and solutions for the digital pathology. The pharmaceutical, biotechnological companies and research organizations wholly rely on software for the analysis & stereology and the quantitative digital pathology. For instance, in 2015, Visiopharm has extended to include Oncotopix Diagnostics which is robust solution for cancer diagnostics.
Some of the key factors such as efficient cost of digital pathology products, ease of virtual transportation of slides, and high efficiency of digital pathology systems are the major factors that boost the growth of the global digital pathology market. In addition, growth in adoption of digital pathology as compared to conventional pathology diagnosis drives the market growth. However, unclear reimbursement policies, dearth of skilled personnel, and unwillingness of older pathologists to adopt new technology hamper the digital pathology market growth. Moreover, rise in initiatives toward commercialization of cost-efficient digital pathology systems is anticipated to offer profitable growth opportunities for service providers in the future.
The key players operating in the field of digital pathology market worldwide include 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Huron Digital Pathology, Leica Biosystems Nussloch GmbH, Hamamatsu Photonics K.K., XIFIN, Inc., Ventana Medical Systems, Inc., Koninklijke Philips N.V., Visiopharm, Indica Labs, Inc. among others.